Boston Scientific Corporation: Constriction, Pathologic trials

The registry lists 19 Constriction, Pathologic studies with Boston Scientific Corporation as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 3 2No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The STEPS - Totalis™ TrialCompletedNCT02079038Not applicableResults posted
• Esophageal Fully Covered Metal Stents in Caustic Strictures StudyCompletedNCT01899300Not applicableResults posted
• WallFlex Esophageal Fully Covered (FC) Benign Anastomotic StrictureCompletedNCT01699542Not applicableResults posted
• WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis StudyCompletedNCT01543256Not applicableResults posted
• WallFlex Biliary Post Liver Transplant IDE PilotCompletedNCT01151280Not applicableResults posted
• WallFlex Biliary Fully Covered (FC) Benign Stricture StudyCompletedNCT01014390Phase 3Results posted
• EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac ArteriesCompletedNCT00896337Phase 3Results posted
• Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct ObstructionCompletedNCT00713427Not applicableResults posted
• Investigating Superion™ In Spinal StenosisCompletedNCT00692276Not applicableResults posted
• ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2011-03)CompletedNCT03752996Not applicable
• Feasibility Trial on ACURATE™ Transapical Implantation in Patients With Severe Symptomatic Aortic Stenosis (2009-01)CompletedNCT03567278Not applicable
• ACURATE™ Transapical Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2010-01)CompletedNCT03143673Not applicable
• Assessing Superion Clinical Endpoints vs. DecompressionWithdrawnNCT03048955Not applicable
• ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval CohortCompletedNCT03003650Not applicable
• ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE TA™ LP Transapical Delivery System in Patients With Severe Aortic StenosisCompletedNCT02986737Not applicable
• ACURATE Neo™ TA Delivery System in Patient With Severe Aortic StenosisCompletedNCT02950428Not applicable
• ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic StenosisCompletedNCT02909556Not applicable
• Prospective, Multi-Center All-Comer Biliary Canadian WallFlex RegistryCompletedNCT02261623
• Pancreatic Metal Stents in Chronic PancreatitisCompletedNCT02135809Not applicable